Atria Wealth Solutions Inc. Has $766,000 Position in ARK Genomic Revolution ETF (BATS:ARKG)

Atria Wealth Solutions Inc. lessened its position in ARK Genomic Revolution ETF (BATS:ARKG) by 1.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,340 shares of the company’s stock after selling 431 shares during the period. Atria Wealth Solutions Inc.’s holdings in ARK Genomic Revolution ETF were worth $766,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth $424,000. Naples Money Management LLC bought a new position in shares of ARK Genomic Revolution ETF during the 4th quarter valued at about $63,000. Sloy Dahl & Holst LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 18.2% during the 4th quarter. Sloy Dahl & Holst LLC now owns 13,492 shares of the company’s stock valued at $443,000 after purchasing an additional 2,079 shares in the last quarter. Elmwood Wealth Management Inc. acquired a new position in shares of ARK Genomic Revolution ETF in the 4th quarter valued at approximately $302,000. Finally, DHK Financial Advisors Inc. increased its stake in ARK Genomic Revolution ETF by 124.2% during the 4th quarter. DHK Financial Advisors Inc. now owns 44,410 shares of the company’s stock worth $1,457,000 after purchasing an additional 24,600 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

Shares of ARKG stock opened at $25.04 on Friday. The business’s 50 day moving average is $27.40 and its 200 day moving average is $28.28.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.